Concord Medical Services Holdings Limited — Cyborg Score 3/10
Weak
Oncology Services and Diagnostic Imaging
Strategic Profile
The company operates through two segments: network and hospital, with its network including radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services. As of (May 2026), the company faces significant valuation pressure with a market cap of $16.98M, reflecting challenges in execution or market sentiment.
Cyborg Score Rationale
Concord Medical exhibits severe operational and market challenges reflected in its dramatically eroded market capitalization and volatility. Trading at distressed valuations with a price significantly below its 52-week highs, the company signals execution risks or structural headwinds in its core cancer treatment and diagnostic imaging business in China.
Top Insights
Market capitalization has collapsed to $16.98M as of May 2026, down from peak valuations, signaling severe market concerns about operational execution or business fundamentals
Stock trading 63.32% below its 52-week high of $10.77 as of May 2026, indicating persistent downward pressure
Company provides clinical support services, equipment leasing, management services, and operates specialty cancer hospitals offering radiation, imaging, laboratory, and inpatient services
Subsidiary Concord Healthcare Group Co., Ltd. is listed on the Main Board of The Stock Exchange of Hong Kong Limited, indicating dual-market strategy
Named Competitors
Cancer Treatment Centers of America — Integrated cancer treatment and diagnostic services
Varian Medical Systems — Radiotherapy equipment and oncology solutions
Elekta — Precision radiation medicine equipment and software
Recent Developments
(April 2026) Concord Healthcare subsidiary filed annual report on Hong Kong Stock Exchange
(December 2025) Company announced 2025 shareholder meeting
(October 2025) Trading resumed following trading halts and volatility pauses
Open the full interactive Concord Medical Services Holdings Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.